148 related articles for article (PubMed ID: 27844130)
1. [Second neoplasms after percutaneous radiotherapy].
Haidl F; Pfister D; Semrau R; Heidenreich A
Urologe A; 2017 Mar; 56(3):342-350. PubMed ID: 27844130
[TBL] [Abstract][Full Text] [Related]
2. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
[TBL] [Abstract][Full Text] [Related]
3. Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.
Hegemann NS; Schlesinger-Raab A; Ganswindt U; Hörl C; Combs SE; Hölzel D; Gschwend JE; Stief C; Belka C; Engel J
Radiat Oncol; 2017 Jan; 12(1):2. PubMed ID: 28049538
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
5. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
6. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
7. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
[TBL] [Abstract][Full Text] [Related]
8. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
10. [Urethral stricture rate after prostate cancer radiotherapy : Five-year data of a certified prostate cancer center].
Kranz J; Maurer G; Maurer U; Deserno O; Schulte S; Steffens J
Urologe A; 2017 Mar; 56(3):336-341. PubMed ID: 28102436
[TBL] [Abstract][Full Text] [Related]
11. Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
Stokkevåg CH; Engeseth GM; Hysing LB; Ytre-Hauge KS; Ekanger C; Muren LP
Acta Oncol; 2015; 54(9):1317-25. PubMed ID: 26230629
[TBL] [Abstract][Full Text] [Related]
12. Is there an increased risk of second primaries following prostate irradiation?
Movsas B; Hanlon AL; Pinover W; Hanks GE
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):251-5. PubMed ID: 9607337
[TBL] [Abstract][Full Text] [Related]
13. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
14. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
15. External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology.
Pistis F; Guedea F; Pera J; Gutierrez C; Ventura M; Polo A; Martinez E; Boladeras A; Ferrer F; Gabriele P; Linares L
Brachytherapy; 2010; 9(1):15-22. PubMed ID: 19734106
[TBL] [Abstract][Full Text] [Related]
16. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
Bhojani N; Capitanio U; Suardi N; Jeldres C; Isbarn H; Shariat SF; Graefen M; Arjane P; Duclos A; Lattouf JB; Saad F; Valiquette L; Montorsi F; Perrotte P; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):342-8. PubMed ID: 20117287
[TBL] [Abstract][Full Text] [Related]
17. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
[TBL] [Abstract][Full Text] [Related]
18. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
Vicini FA; Kestin LL; Martinez AA
Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
Takam R; Bezak E; Yeoh EE
Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
[TBL] [Abstract][Full Text] [Related]
20. [Focal dose escalation in the treatment of prostate cancer : Long-term results of HDR brachytherapy].
Cordes J; Broschk J; Sommerauer M; Jocham D; Merseburger AS; Melchert C; Kovács G
Urologe A; 2017 Feb; 56(2):157-166. PubMed ID: 27376359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
